A cancer treatment that one expert called the 'most exciting thing I've seen in my lifetime' just got approved to treat more patients (NVS, GILD)

Reuters

• The FDA just approved a cutting-edge therapy to treat more patients with certain forms of blood cancer.
• It's the second approval for the drug, Kymriah, which is now approved to treat certain forms of leukemia and lymphoma.  
• The therapy works by taking a person's own cells, reprogramming them, and inserting them back into the body to fight the cancer — in this case, certain forms of blood cancer.

The FDA just approved a cutting-edge cancer therapy to treat another form of blood cancer. 

It's the second approval for Kymriah, also known as tisagenlecleucel, this time to treat patients with large B-cell lymphoma, and the first for adult patients. An August approval of Kymriah approved the therapy to treat pediatric acute lymphoblastic leukemia in people up to age 25.See the rest of the story at Business Insider

NOW WATCH: What too much exercise does to your body and brain

See Also:

• A Yale skin cancer expert says the popular notion that you need to soak up Vitamin D from the sun is a myth
• You are probably not getting enough sleep, and it is killing you
• 25 of the most dangerous things science has strongly linked to cancer

SEE ALSO: A startup that's making 'superblood' to treat conditions like cancer just raised $100 million to get its treatments through key trials